| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.0041 | 1 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.0027 | 1 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0026 | 1 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.0025 | 1 |